These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22372505)

  • 1. Cytokine network: new targeted therapy for pancreatic cancer.
    Matsuo Y; Takeyama H; Guha S
    Curr Pharm Des; 2012; 18(17):2416-9. PubMed ID: 22372505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting the cancer-stroma interaction: a potential approach for pancreatic cancer treatment.
    Li X; Ma Q; Xu Q; Duan W; Lei J; Wu E
    Curr Pharm Des; 2012; 18(17):2404-15. PubMed ID: 22372501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting tumor micro-environment for design and development of novel anti-angiogenic agents arresting tumor growth.
    Gacche RN; Meshram RJ
    Prog Biophys Mol Biol; 2013 Nov; 113(2):333-54. PubMed ID: 24139944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting hypoxic tumor microenvironment in pancreatic cancer.
    Tao J; Yang G; Zhou W; Qiu J; Chen G; Luo W; Zhao F; You L; Zheng L; Zhang T; Zhao Y
    J Hematol Oncol; 2021 Jan; 14(1):14. PubMed ID: 33436044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reshaping the Tumor Stroma for Treatment of Pancreatic Cancer.
    Vennin C; Murphy KJ; Morton JP; Cox TR; Pajic M; Timpson P
    Gastroenterology; 2018 Mar; 154(4):820-838. PubMed ID: 29287624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crosstalk between stromal cells and cancer cells in pancreatic cancer: New insights into stromal biology.
    Zhan HX; Zhou B; Cheng YG; Xu JW; Wang L; Zhang GY; Hu SY
    Cancer Lett; 2017 Apr; 392():83-93. PubMed ID: 28189533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interventions that induce modifications in the tumor microenvironment.
    Bernhard EJ
    Cancer Radiother; 2011 Aug; 15(5):376-82. PubMed ID: 21571567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Wnt/β-catenin signaling in drug resistance of pancreatic cancer.
    Cui J; Jiang W; Wang S; Wang L; Xie K
    Curr Pharm Des; 2012; 18(17):2464-71. PubMed ID: 22372504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular Pathogenesis and Targeted Therapy of Pancreatic Cancer.
    Tanaka S
    Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S197-205. PubMed ID: 25749932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of pancreatic cancer dissemination: the role of the chemokine system.
    Marchesi F; Grizzi F; Laghi L; Mantovani A; Allavena P
    Curr Pharm Des; 2012; 18(17):2432-8. PubMed ID: 22372498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiogenesis and the tumor microenvironment: vascular endothelial growth factor and beyond.
    Mittal K; Ebos J; Rini B
    Semin Oncol; 2014 Apr; 41(2):235-51. PubMed ID: 24787295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific chemotherapeutic agents induce metastatic behaviour through stromal- and tumour-derived cytokine and angiogenic factor signalling.
    Liu G; Chen Y; Qi F; Jia L; Lu XA; He T; Fu Y; Li L; Luo Y
    J Pathol; 2015 Oct; 237(2):190-202. PubMed ID: 25988668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting stroma in pancreatic cancer: Promises and failures of targeted therapies.
    Bahrami A; Khazaei M; Bagherieh F; Ghayour-Mobarhan M; Maftouh M; Hassanian SM; Avan A
    J Cell Physiol; 2017 Nov; 232(11):2931-2937. PubMed ID: 28083912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis in pancreatic cancer: current research status and clinical implications.
    Li S; Xu HX; Wu CT; Wang WQ; Jin W; Gao HL; Li H; Zhang SR; Xu JZ; Qi ZH; Ni QX; Yu XJ; Liu L
    Angiogenesis; 2019 Feb; 22(1):15-36. PubMed ID: 30168025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of pre-clinical and clinical studies targeting angiogenesis in pancreatic ductal adenocarcinoma.
    Craven KE; Gore J; Korc M
    Cancer Lett; 2016 Oct; 381(1):201-10. PubMed ID: 26723874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic cancer stroma: understanding biology leads to new therapeutic strategies.
    Rucki AA; Zheng L
    World J Gastroenterol; 2014 Mar; 20(9):2237-46. PubMed ID: 24605023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-associated fibroblasts in pancreatic adenocarcinoma.
    Pan B; Liao Q; Niu Z; Zhou L; Zhao Y
    Future Oncol; 2015 Sep; 11(18):2603-10. PubMed ID: 26284509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory cytokines in human pancreatic cancer.
    Roshani R; McCarthy F; Hagemann T
    Cancer Lett; 2014 Apr; 345(2):157-63. PubMed ID: 23879960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis.
    Wente MN; Keane MP; Burdick MD; Friess H; Büchler MW; Ceyhan GO; Reber HA; Strieter RM; Hines OJ
    Cancer Lett; 2006 Sep; 241(2):221-7. PubMed ID: 16458421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of growth, invasion, and metastasis of human pancreatic carcinoma cells by NK4 in an orthotopic mouse model.
    Tomioka D; Maehara N; Kuba K; Mizumoto K; Tanaka M; Matsumoto K; Nakamura T
    Cancer Res; 2001 Oct; 61(20):7518-24. PubMed ID: 11606388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.